Cita APA

Cruz Merino, L. d. l., Gion, M., Cruz Jurado, J., Quiroga, V., Andrés, R., Moreno, F., . . . Rojo, F. (2021). Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study.

Citación estilo Chicago

Cruz Merino, Luis de la, María Gion, Josefina Cruz Jurado, Vanesa Quiroga, Raquel Andrés, Fernando Moreno, Carlos Jiménez Cortegana, Víctor Sánchez Margalet, y Federico Rojo. Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study. 2021.

Cita MLA

Cruz Merino, Luis de la, et al. Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study. 2021.